⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
INMB News
INmune Bio Inc. Common stock
Form 8-K
sec.gov
INMB
INmune Bio Reports Statistically Significant Treatment Effect on Advanced White Matter MRI Biomarker in Phase 2 MINDFuL Alzheimer's Trial
globenewswire.com
INMB
Three TriKE Candidates In Clinic As NK Cell Engager Field Reorganizes
prnewswire.com
NKTX
GTBP
IBRX
FATE
INMB
INmune Bio Publishes Phase 2 MINDFuL Trial Results in NPJ Dementia, Advancing the XPro™ Platform
globenewswire.com
INMB
Form 8-K
sec.gov
INMB
INmune Bio Receives FDA Fast Track Designation for XPro1595 in Early Alzheimer's Disease
globenewswire.com
INMB
INmune Bio Named Founding Member of the American Biotech Innovation Alliance (ABIA) as U.S. Biotech Sector Navigates Strategic Inflection Point
globenewswire.com
INMB
INmune Bio Inc. Announces First Quarter 2026 Results and Provides Business Update
globenewswire.com
INMB
Form 8-K
sec.gov
INMB
INmune Bio and Anthony Nolan Announce Strategic Expansion of CORDStrom™ MSC Platform Collaboration to Target RDEB, Oncology, and Inflammatory Diseases
globenewswire.com
INMB